Pfizer Australia Pty Ltd has been granted provisional approval by the Therapeutic Goods Administration (TGA) for COMIRNATY, its COVID-19 vaccine. As a result, the vaccine is now included in the Australian Register of Therapeutic Goods for active immunisation to prevent COVID-19 in individuals 16 years or older. MORE.
- February 8, 2021
Russell Kennedy (Melbourne/Sydney): TGA provisionally approves Pfizer COVID-19 vaccine
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email